Organic compounds -- part of the class 532-570 series – Organic compounds – Unsubstituted hydrocarbyl chain between the ring and the -c-...
Reexamination Certificate
2007-08-14
2007-08-14
Coleman, Brenda (Department: 1624)
Organic compounds -- part of the class 532-570 series
Organic compounds
Unsubstituted hydrocarbyl chain between the ring and the -c-...
C549S267000
Reexamination Certificate
active
10366776
ABSTRACT:
Biologically active compounds related to the bryostatin family of compounds, having simplified spacer domains and/or improved recognition domains are disclosed, including methods of preparing and utilizing the same.
REFERENCES:
patent: 4560774 (1985-12-01), Pettit et al.
patent: 4611066 (1986-09-01), Pettit et al.
patent: 4833257 (1989-05-01), Pettit et al.
patent: 5072004 (1991-12-01), Pettit
patent: 5328929 (1994-07-01), Pettit et al.
patent: 5358711 (1994-10-01), May et al.
patent: 5891870 (1999-04-01), Dreidger et al.
patent: 6043270 (2000-03-01), Driedger et al.
patent: 6060505 (2000-05-01), Blumberg et al.
patent: 6624189 (2003-09-01), Wender et al.
patent: 2003/0199469 (2003-10-01), Schwartz et al.
patent: 2003/0233000 (2003-12-01), Lindquist et al.
patent: 0264173 (1988-04-01), None
patent: 0324574 (1993-11-01), None
patent: WO 01/11024 (2001-02-01), None
Wender et al., Selective Binding of Bryostatin Analogues to the Cysteine Rich Domains of Protein Kinase C Isozymes, Bioorganic & Medicinal Chemistry Letters, vol. 9, No. 12, pp. 1687-1690, Jun. 1999.
Wender et al., Synthesis and Biological Evaluation of a New Class of Bryostatin Analogues: the Role of the C20 Substituent in Protein Kinase C Binding, Tetrahedron Letters, vol. 41, No. 35, pp. 6725-6729, Aug. 2000.
Pettit, G.R., “The bryostatins,”Fortschritte der Chemie Organischer Naturstoffe—Progress in the Chemistry of Natural Products, 57:153-195 (1991).
Registry printout of Bryostatin 4, 5, 10 and 15, 2003.
Baryza, J.L.; Brenner, S.E.; Craske, M.L.; Meyer, T.; Wender, P.A., “Simplified Analogs of Bryostatin with Anticancer Activity Display Greater Potency for Translocation of PKCδ-GFP”,Chemistry&Biology, vol. 11; pp. 1261-1267 (2004).
Evans, D.A.; Carter, P.H.; Carreira, E.M.; Prunet, J.A.; Charette, A.B.; Lautens, M., “Asymmetric Synthesis of Bryostatin 2”,Angew. Chem. Int. Ed. Engl., vol. 37 (17); pp. 2354-2359 (1998).
Evans, D.A.; Carter, P.H.; Carreira, E.M.; Charette, A.B.; Prunet, J.A.; Lautens, M., “Total Synthesis of Bryostatin 2”,J. Am. Chem. Soc., vol. 121; pp. 7540-7552 (1999).
Hale, K.J.; Hummersone, M.G.; Bhatia, G.S., “Control of Olefin Geometry in the Bryostatin B-Ring through Exploitation of a C2-Symmetry Breaking Tactic and a Smith-Tietze Coupling Reaction”,Organic Letters, vol. 2; pp. 2189-2192 (2000).
Hale, K.J.; Frigerio, M.; Manaviazar, S.; Hummersone, M.G.; Fillingham, I.J.; Barsukov, I.G.; Damblon, C.F.; Gescher, A.; Roberts, G.C.K., “Synthesis of a Simplified Bryostatin C-Ring Analogue That Binds to the CRD2 of Human PKC-α and Construction of a Novel BC-Analogue by an Unusual Julia Olefination Process”,Organic Letters, vol. 5; pp. 499-502 (2003).
Hale, K.J.; Frigerio, M.; Manaviazar, S., “New, Abridged Pathway to Masamune's “Southern Hemisphere” Intermediate for the Total Synthesis of Bryostatin 7” ,Organic Letters, vol. 5; pp. 503-505 (2003).
Harada, T.; Inoue, A.; Wada, I.; Uchimura, J-J.; Tanaka, S.; Oku, A., “Stereoselective Acetilization of 1,3-Alkanediols Controlled by Intramolecular van der Waals Attractive Interactions and Its Application to an Enantiodifferentiating Transformation of σ-Symmetric 1,3,5-Pentanetriols”,J. Am. Chem. Soc., vol. 115; pp. 7665-7674 (1993).
Kageyama, M.; Tamura, T., “Synthesis of Bryostatin 7”,J. Am. Chem. Soc., vol. 112; pp. 7407-7408 (1990).
López-Pelegrin, J.A.; Wentworth, P.; Sieber, F.; Metz, W.A.; Janda, K.D., “Soluble Polymer-Supported Chemoenzymatic Synthesis of the C21-C27 Fragment of the Bryostatins”,J. Org. Chem., vol. 65; pp. 8527-8531 (2000).
Masamune, S., “Asymmetric Synthesis and Its Applications: Towards the Synthesis of Bryostatin 1”,Pure&Applied Chemistry, vol. 60; pp. 1587-1596 (1988).
Masamune, S., “Asymmetric Synthesis and Its Applications: Towards the Synthesis of Bryostatin 1”,Chimica, vol. 42: pp. 210-211 (1988).
O'Brian, M.; Taylor, N.H.; Thomas, E.J., “Synthesis of the C(1)-C(16) Fragment of Bryostatins”,Tetrahedron Letters, vol. 43: pp. 5491-5494 (2002).
Ohmori, K.; Ogawa, Y.; Obitsu, T.; Ishikawa, Y.; Nishiyama, S.; Yamamura, S., “Total Synthesis of Bryostatin 3”,Angew. Chem. Int. Ed. Engl., vol. 39: pp. 2290-2294 (2000).
Pettit, G.R.; Herald, C.L.; Doubek, D.L.; Herald, D.L., “Isolation and Structure of Bryostatin 1”,J. Am. Chem. Soc., vol. 104: pp. 6846-6848 (1982).
Pettit, G.R., “Progress in the Discovery of Biosynthetic Anticancer Drugs”,J. Natural Products, vol. 59: pp. 812-821 (1996).
Theisen, P.D.; Heathcock, C.H., “Improved Procedure for Preparation of Optically Active 3-Hydroxyglutarate Monoesters and 3-Hydroxy-5-oxoalkanoic Acids”,J. Org. Chem., Vol. 53: pp. 2374-2378 (1988).
Vakalopoulos, A.; Lampe, T.F.J.; Hoffmann, H.M.R., “Asymmetric Synthesis of the Northern Half C1-C16of the Bryostatins”,Organic Letters, vol.3: pp. 929-932 (2001).
Voight, E.A.; Roethle, P.A.; Burke, S.D., “Concise Formal Synthesis of the Bryostatin Southern Hemisphere (C17-C27)”,J. Org. Chem., vol. 69: pp. 4534-4537 (2004).
Voight, E.A.; Seradj, H.; Roethle, P.A.; Burke, S.D., “Synthesis of the Bryostatin 1 Northern Hemisphere (C1-C16) via Desymmetrization by Ketalization/Ring-Closing Metathesis”,Organic Letters, vol. 6: pp. 4045-4048 (2004).
Wender, P.A.; Cribbs, C.M.; Koehler, K.F.; Sharkey, N.A.; Herald, C.L.; Kamano, Y.; Pettit, G.R.; Blumberg, P.M., “Modeling of the Bryostatins to the Phorbol Ester Pharmacophore on Protein Kinase C”,Proc. Natl. Acad. Sci., USA, vol. 85: pp. 7197-7201 (1988).
Wender, P.A.; Irie, K.; Miller, B., “Identification, Activity, and Structural Studies of Peptides Incorporating the Phorbol Ester-Binding Domain of Protein Kinase C”,Proc. Natl. Acad. Sci., USA, vol. 92: pp. 239-243 (1995).
Wender, P.A.; Brabander, J.D.; Harran, P.G.; Jimenez, J-M.; Koehler, M.F.T.; Lippa, B.; Park, C.-M.; Shiozaki, M., “Synthesis of the First Members of a New Class of Biologically Active Bryostatin Analogues”, J. Am. Chem. Soc., vol. 120: pp. 4534-4535 (1998).
Wender, P.A.; DeBrabander, J.; Harran, P.G.; Jimenez, J.-M.; Koehler, M.F.T.; Lippa, B.; Park, C.-M.; Siedenbiedel, C.; Pettit, G.R., “The Design, Computer Modeling, Solution Structure, and Biological Evaluation of Synthetic Analogues of Bryostatin 1”,Proc. Natl. Acad. Sci., USA, vol. 95: pp. 6624-6629 (1998).
Wender, P.A.; DeBrabander, J.; Harran, P.G.; Hinkle, K.W.; Lippa, B.; Pettit, G.R., “Synthesis and Biological Evaluation of Fully Synthetic Bryostatin Analogues”,Tetrahedron Letters, vol. 39: pp. 8625-8628 (1998).
Wender, P.A.; Lippa, B., “Synthesis and Biological Evaluation of Bryostatin Analogues: The Role of the A-Ring”,Tetrahedron Letters, vol. 41: pp. 1007-1011 (2000).
Wender, P.A.; Baryza, J.L.; Bennett, C.E.; Bi, F.C.; Brenner, S.E.; Clarke, M.O.; Horan, J.C.; Kan, C.; Lacote, E.; Lippa, B.; Nell, P.G.; Turner, T.M., “The Practical Synthesis of a Novel and Highly Potent Analogue of Bryostatin”,J. Am. Chem. Soc., vol. 124: pp. 13648-13649 (2002).
Wender, P.A.; Maywey, A.V.W.; VanDeusen, C.L., “A Concise, Selective Synthesis of the Polyketide Spacer Domain of a Potent Bryostatin Analogue”,Organic Letters, vol. 5: pp. 277-279 (2003).
Wender, P.A.; Koehler, M.F.T.; Sendzik, M., “A New Synthetic Approach to the C Ring of Known as Well as Novel Bryostatin Analogues”,Organic Letters, vol. 5: pp. 4549-4552 (2003).
Hinkle Kevin W.
Lippa Blaise
Park Cheol-Min
Wender Paul A.
Coleman Brenda
King & Spalding
The Board of Trustees of the Leland Stanford Junior University
LandOfFree
Bryostatin analogues, synthetic methods and uses does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Bryostatin analogues, synthetic methods and uses, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bryostatin analogues, synthetic methods and uses will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3868226